Authors:
Chi, LG
Mertz, TE
Rogers, KL
Janiczek, N
Peng, YW
Saganek, L
Bousley, RF
Juneau, PL
Uprichard, ACG
Gallagher, KP
Citation: Lg. Chi et al., Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: Comparison with inogatran, J THROMB TH, 11(1), 2001, pp. 19-31
Authors:
Loeffler, DA
Camp, DM
Juneau, PL
Harel, E
LeWitt, PA
Citation: Da. Loeffler et al., Purine-induced alterations of dopamine metabolism in rat pheochromocytoma PC12 cells, BRAIN RES B, 52(6), 2000, pp. 553-558
Authors:
Laemont, KD
Schaefer, CJ
Juneau, PL
Schrier, DJ
Citation: Kd. Laemont et al., Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats, INT J IMMUN, 21(11), 1999, pp. 711-725
Citation: Dp. Ignasiak et al., Effects of intravenous enoxaparin and intravenous inogatran in an electrolytic injury model of venous thrombosis in the dog, J THROMB TH, 6(3), 1998, pp. 199-206
Authors:
Loeffler, DA
LeWitt, PA
Juneau, PL
Camp, DM
Arnold, LA
Hyland, K
Citation: Da. Loeffler et al., Time-dependent effects of levodopa on regional brain dopamine metabolism and lipid peroxidation, BRAIN RES B, 47(6), 1998, pp. 663-667
Authors:
Iyer, RN
Davis, MD
Juneau, PL
Giordani, AB
Citation: Rn. Iyer et al., Brain extracellular levels of the putative antipsychotic CI-1007 and its effects on striatal and nucleus accumbens dopamine overflow in the awake rat, J PHARM PHA, 50(10), 1998, pp. 1147-1153